Wearable Medical FPC Design

ByCable Assembly Manufacturer

Posted by SZFRS Engineering Team

Wearable medical FPC (Flexible Printed Circuit) design balances multiple competing requirements simultaneously — signal integrity, biocompatibility, mechanical flex life, patient safety, and regulatory compliance — all within the extreme miniaturization that wearable medical devices require. Continuous glucose monitors (CGM) like Dexcom G7 and Abbott FreeStyle Libre, wearable ECG patches like Zio and Cardea SOLO, smart drug delivery patches, and continuous patient monitors all rely on FPC technology to deliver reliable signal capture from skin-contact sensors to onboard electronics. The design space involves trade-offs between signal performance, mechanical durability, biocompatibility regulation, and manufacturability. This guide covers wearable medical FPC design from first principles through specific design rules with the engineering depth that wearable medical product teams need.

Get a Wearable Medical Quote

TL;DR — Wearable Medical FPC in One Page

Wearable medical FPC design follows the framework: Substrate typically polyimide (PI) for flex life and dielectric performance; LCP (Liquid Crystal Polymer) for high-frequency or extreme thin applications. Conductor typically rolled-annealed copper (RAC) at 1/2 oz or 1 oz for flex life. Stack-up single-sided for simple sensors, double-sided for processing electronics, multilayer (4-6 layers) for dense designs. Bend radius minimum 6-10x total FPC thickness for static bend; 20x for flex life. Biocompatibility path: cover materials and adhesives must pass ISO 10993 series testing for skin contact; FPC encapsulation chemistry must not leach. EMI shielding via ground plane or cover film for high-impedance sensors. Signal integrity design rules for high-speed digital and analog physiological signals. Trace patterns avoid sharp corners, use teardrops at vias, balance copper distribution. Below covers each in detail.

FPC Substrate Material Selection

Polyimide (PI)

The dominant substrate for wearable medical FPC:

  • Temperature range. -200 to +260 °C continuous service. Tolerates lead-free reflow soldering.
  • Flex life. Excellent. Handles millions of bend cycles in optimized designs.
  • Dielectric properties. εr ≈ 3.4-3.5 at 1 GHz. Stable across temperature and frequency.
  • Chemical resistance. Excellent. Resists most chemicals; some specialty acids and solvents affect it.
  • Thicknesses. 25 µm, 50 µm, 75 µm typical. Thicker for stiffer; thinner for higher flexibility.
  • Standard products. DuPont Kapton (the original PI brand), Kaneka APICAL, multiple equivalent products from other manufacturers.
  • Cost. Premium over PVC or PET but standard for FPC; substrate cost is small portion of total FPC cost.

Liquid Crystal Polymer (LCP)

For high-frequency and very thin applications:

  • Lower dielectric constant. εr ≈ 3.0-3.2. Better for high-frequency signal integrity.
  • Lower moisture absorption. Maintains electrical properties in humid environments.
  • Thinner achievable. 12 µm and below available; ultra-thin FPCs use LCP.
  • Higher cost. 2-3x polyimide.
  • Standard products. Kuraray Vecstar, Sumitomo Bakelite Sumikon LCP.

PEN and Other Substrates

PEN (Polyethylene Naphthalate) and PET (Polyethylene Terephthalate) are lower-cost alternatives for cost-sensitive applications. Lower temperature ratings limit their use; not common in medical FPC where solder reflow is required.

Conductor Selection

  • Rolled-annealed copper (RAC). Best flex life. Anneal step in production produces favorable grain structure for repeated flexing. Standard for medical wearable FPC.
  • Electrodeposited copper (ED). Lower cost but less flex life. Used in static-flex FPC where bend cycles are limited.
  • Copper thickness. 1/2 oz (17.5 µm), 1 oz (35 µm), 2 oz (70 µm) typical. Thinner for higher flexibility; thicker for higher current carrying.
  • Plating. Tin plating standard for solder pads; gold plating for connector contacts; ENIG (Electroless Nickel Immersion Gold) for fine-pitch component placement.

Stack-Up Design

FPC stack-up choice depends on circuit complexity and signal requirements:

Single-Sided FPC

The simplest construction:

  • Polyimide substrate (25-75 µm).
  • Conductor pattern on one side (RAC, 17.5-35 µm).
  • Cover film (polyimide, 25 µm).
  • Total thickness: 50-150 µm typical.

Application: Simple sensor connections, signal routing, biopotential electrode arrays. Most CGM sensor extensions use single-sided FPC.

Double-Sided FPC

Conductors on both sides connected via plated through-holes:

  • Substrate with conductor on both sides.
  • Plated through-holes (PTH) connect layers.
  • Cover films on both sides.
  • Total thickness: 100-250 µm.

Application: ECG patches with onboard processing, ambient sensor patches, smart drug delivery patches with integrated electronics.

Multilayer FPC

4-6 layers for dense designs. Used in wearable medical devices with significant onboard processing — ECG patches with onboard analog front-end, biopotential amplifiers, microcontroller, and wireless radio. Cost premium 2-4x single-sided. Standard manufacturing process aligned with rigid PCB multilayer techniques.

Rigid-Flex FPC

Rigid sections (where electronics mount) integrated with flex sections (for mechanical flex). Combines benefits of rigid PCB (component density, ease of assembly) with flex PCB (mechanical adaptation). Standard for advanced wearable medical devices. Cost premium 2-4x equivalent multilayer flex.

Bend Radius and Mechanical Design

FPC bend behavior follows specific rules:

  • Static bend. Single bend, no repetitive cycling. Minimum bend radius: 6x total FPC thickness for single-sided; 8x for double-sided; 10x for multilayer.
  • Flex (millions of cycles). Repeated bending. Minimum bend radius: 100-200x total thickness for typical flex life requirements.
  • Dynamic flex (high cycle). Repeated bending in production environment. Minimum bend radius: 200-500x total thickness with optimized design.
  • Folding (Z-fold). Sharp folds in static configuration. Minimum 6x total thickness, but specific fold design required.

Conductor pattern design for flex:

  • Trace orientation: traces should run perpendicular to the bend axis. Parallel traces on the bend axis stretch and compress less than perpendicular traces.
  • Avoid sharp corners. Use 45° or curved transitions.
  • Avoid pads in bend zones.
  • Balance copper distribution. Heavy copper on one side and light on the other distorts the bend axis.
  • Stiffener patches at component attachment points.

Failure to follow these rules can embarass design teams during validation testing — flex life test failures, traces breaking unexpectedly, or pads delaminating from substrate. The conventional rules came from decades of empirical testing and shouldn’t be ignored.

Biocompatibility — ISO 10993 Path

For skin-contact wearable medical FPC, biocompatibility per ISO 10993 series is required. The relevant tests:

  • ISO 10993-5. Cytotoxicity. The most basic biocompatibility test — does the material kill cells in culture? Required for most medical applications.
  • ISO 10993-10. Irritation and skin sensitization. Required for skin-contact applications. Tests whether material causes irritation or allergic response.
  • ISO 10993-23. Specifically for skin sensitization (newer guidance, more sensitive).
  • ISO 10993-11. Systemic toxicity. Required for prolonged skin contact (24+ hours).
  • ISO 10993-3. Genotoxicity, carcinogenicity, reproductive toxicity. Required for some long-term contact applications.
  • ISO 10993-1. Evaluation and testing within a risk management process. The framework standard.

For typical wearable medical FPC, the relevant materials requiring biocompatibility documentation:

  • FPC substrate (polyimide). Most medical-grade polyimide formulations have established ISO 10993 documentation.
  • Cover film material. Same biocompatibility requirements as substrate.
  • Adhesives. Pressure-sensitive adhesives, conductive adhesives, encapsulation adhesives — all require biocompatibility testing.
  • Skin-contact electrode materials (Ag/AgCl pastes, gold plating, hydrogel electrolytes). Each requires biocompatibility documentation.
  • Encapsulation compound for full electronics encapsulation.

Test reports from material suppliers usually cover initial biocompatibility, but the device-specific biocompatibility evaluation per ISO 10993-1 still applies — test the assembled device, not just the materials. The device evaluation may surface interactions between materials that individual material tests don’t catch.

EMI Shielding for High-Impedance Sensors

Wearable medical sensors capture biopotentials at very low signal levels — ECG signals are millivolts, EEG signals are microvolts, brainwave signals require sub-microvolt resolution. Electromagnetic interference (EMI) from cellular phones, WiFi, fluorescent lighting can swamp the desired signal. EMI shielding strategies:

  • Ground plane. Continuous ground plane on one or more layers shields traces from external interference. Standard for ECG and EMG patches.
  • Shield film. Conductive cover film over signal traces. Used in single-sided FPC where ground plane isn’t possible.
  • Differential signaling. ECG and EMG channels typically use differential signaling. Common-mode interference cancels in the differential measurement.
  • Shielded cable extensions. If the sensor has a cable extension to external electronics, shielded cable is essential.
  • Filter components. Onboard low-pass filters reject high-frequency interference.

Signal Integrity for Physiological Signals

Physiological signals span a wide bandwidth:

  • EEG (Electroencephalogram). 0.5-100 Hz. Sub-microvolt amplitude. Highest sensitivity requirement.
  • ECG (Electrocardiogram). 0.05-150 Hz. Millivolt amplitude.
  • EMG (Electromyogram). 20-500 Hz. Millivolt amplitude.
  • Photoplethysmography (PPG, optical heart rate). DC to 100 Hz. Optical signal converted to electrical.
  • Electrochemical (CGM glucose). Slow signals (seconds to minutes). Nanoampere-level currents.
  • Bioimpedance. 1-1000 kHz. Used in body composition analysis and heart rate monitors.

FPC design for these signals requires attention to:

  • Trace impedance (controlled for high-frequency signals).
  • Trace shielding (ground plane or shield film).
  • Component placement (analog and digital separated).
  • Power supply decoupling (clean DC for sensitive sensors).
  • Reference voltage routing (low-noise reference for analog-to-digital conversion).

Real-World Case Study — Wearable ECG Patch FPC

A digital health customer was developing a wearable ECG patch — a stick-on device worn on the chest for 7-14 days continuous ECG monitoring. The product specifications:

  • FPC dimensions: 30 mm × 80 mm × ~150 µm thick.
  • Construction: Multilayer (4 layers) FPC with ground plane and dedicated analog/digital sections.
  • Skin contact electrodes: Two Ag/AgCl pads, 3 cm apart.
  • Onboard electronics: Analog front-end, ADC, MCU, BLE radio, battery.
  • Biocompatibility: ISO 10993-5/-10 documented at material level.
  • Wear duration: 14 days continuous.
  • Volume: 100,000 units in year 1, scaling to 500,000+.

Engineering challenges encountered during development:

  • Bend life initially insufficient. First prototypes failed flex life testing at 50,000 cycles vs target 200,000. Root cause: traces routed in bend zone with sharp corners. Redesign moved traces parallel to bend axis with rounded corners; bend life rose to 500,000+ cycles.
  • Sweat moisture ingress. Initial encapsulation failed in 7-day human wear testing. Sweat penetrated cover film and corroded internal components. Redesign added second-layer encapsulation with moisture-blocking adhesive.
  • EMI from cellular phone. Patient testing surfaced EMI events when patient’s phone was nearby. Original design lacked complete ground plane. Redesign added continuous ground plane on layer 2; EMI events disappeared.
  • Skin reaction. Beta study showed 4% of users developed mild skin irritation. Trace components in pressure-sensitive adhesive were the culprit. Switched to a different medical-grade PSA with different chemistry; subsequent study showed irritation rate <1%.

The product launched on schedule with 100,000 units in year 1. Year 2 expanded to 350,000 units. Year 3 reached 600,000 units. The investment in proper FPC design — proper bend zones, ground plane, encapsulation, biocompatible adhesive — paid back through reliable field performance and zero adverse events through 1,000,000+ cumulative wear-days.

This pattern — wearable medical FPC requiring iterative design and validation through human wear studies — is the new normal for wearable medical product development. Skipping the iteration produces products that fail in field use; investing in iteration produces products that succeed.

Common Wearable Medical FPC Mistakes

Patterns we see:

Skipping flex life testing. Designs deemed adequate based on visual review fail in real-world use. Always run flex life testing on representative samples.

Inadequate biocompatibility documentation. Material-level certificates aren’t enough; device-level biocompatibility evaluation per ISO 10993-1 is required. Building this on top of existing material certificates is straightforward but takes time.

Ignoring sweat and moisture ingress. Indoor lab testing doesn’t simulate days of human wear. Real human wear studies surface moisture-related failures.

EMI immunity not validated. Real-world EMI from cellular phones, WiFi, microwave ovens, fluorescent lighting can swamp signal. Validate with realistic EMI exposure.

Underestimating regulatory documentation effort. FPC design changes require updating Design History File. Plan for this overhead.

Bottom Line

Wearable medical FPC design balances signal integrity, mechanical flex life, biocompatibility, and patient safety in extreme miniaturization. Substrate choice (polyimide standard, LCP for high-frequency or thin), conductor selection (RAC for flex life), stack-up (single-sided through multilayer), and rigid-flex hybrid options provide the design palette. Bend radius rules (6-10x for static, 100-500x for flex life) drive mechanical reliability. ISO 10993 biocompatibility documentation extends beyond material level to device level. EMI shielding via ground plane or shield film protects sensitive physiological signals. For wearable medical product teams, working with FPC manufacturers experienced in medical applications — for biocompatibility documentation, design rule depth, and regulatory submission support — speeds time to market and reduces development risk.

Related Reading

Wearable Medical FPC Quote?

Send us your wearable medical product specification — sensor type, FPC dimensions, layer count, biocompatibility requirements, and target volumes. We’ll quote within 5-10 days with full ISO 10993 alignment, design rule consultation, and regulatory documentation support.

Contact Us for Wearable Medical Quote

Similar Posts